Shortages drive 4,500% price markup; Disgruntled IT worker hacks pharma company, deletes hosts;

> Amid growing drug shortages, some back-door suppliers are jacking up prices for meds to treat a number of conditions, including cancer and high blood pressure, by as much as 4,500%. Article

> Six Sigma is most appropriate for supplies or processes over which a company has tight control, and it might not be suitable for every aspect of pharmaceutical manufacturing. Story

> A former IT administrator at Japanese pharmaceutical company Shionogi has pleaded guilty to hacking the company network and deleting 15 VMware hosts. News

> Ranbaxy Laboratories is shutting down its quality-challenged manufacturing plant in Gloversville, NY. Item

> The thousands of job losses anticipated when Pfizer ($PFE) pulls up stakes in Sandwich, U.K., will initiate a recovery that could take 10 years, say officials. Report

> Hiring is increasing in Russia at multinational pharma companies, and the sector is among the three most active in terms of recruiting employees. Story

> Ampac Fine Chemicals ($APFC) will begin manufacturing the API for its smallpox drug at its recently completed facility in Rancho Cordova, ending its contract manufacturing agreement with Chimerix. Item

> Intellipharmaceutics ($IPCI) and Par Pharmaceutical ($PRX) have added the development and commercialization of additional strengths of generic Focalin XR to their agreement. Release